Eicosanoids in breast cancer patients before and after mastectomy (Q41119809)

27 September 2017

Eicosanoids in breast cancer patients before and after mastectomy (English)

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

13 October 2022

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

13 October 2022

author name string

van Dam JJ

3

1 reference

27 September 2017

van der Ham AC

4

1 reference

27 September 2017

van der Ingh HF

6

1 reference

27 September 2017

van Wilgenburg MG

8

1 reference

27 September 2017

W. J. Kort

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

A. M. Bijma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

J. J. van Dam

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

A. C. van der Ham

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

J. M. Hekking

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

H. F. van der Ingh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

W. S. Meijer

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

M. G. van Wilgenburg

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

F. J. Zijlstra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1603822

13 October 2022

language of work or name

1 reference

1 April 1992

1 reference

full work available at URL

27 September 2017

https://api.elsevier.com/content/article/PII:0952327892900906?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

https://api.elsevier.com/content/article/PII:0952327892900906?httpAccept=text/plain

13 October 2022

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostaglandins, Leukotrienes and Essential Fatty Acids

13 October 2022

published in

1 reference

27 September 2017

45

1 reference

27 September 2017

4

1 reference

27 September 2017

319-327

1 reference

Prostaglandins in cancer: a review

27 September 2017

2

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

The concentration of 6-keto-PGF1α and TXB2 in plasma samples from patients with benign and malignant tumours of the breast

13 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostaglandin E2 and cyclic nucleotides in plasma and urine of colonic cancer patients

13 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostacyclin and thromboxane in benign and malignant breast tumours

13 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostaglandins in breast cancer: relationship to disease stage and hormone status

13 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Relationship of tumor prostaglandin levels to early recurrence in women with primary breast cancer: clinical update

13 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostaglandins and prognosis in human breast cancer

13 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Plasma prostaglandins in hypercalcemic patients with neoplastic disease

13 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications

13 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Regulation of the immune response by prostaglandins

13 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Plasma eicosanoids and platelet aggregation as parameters to monitor tumor patients. A study in 12 healthy subjects to obtain baseline levels

13 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Eicosanoid profile of healing colon anastomosis and peritoneal macrophages in the rat.

13 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Misoprostol provides a colonic mucosal protective effect during acetic acid-induced colitis in rats

13 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostaglandin F2 alpha in benign and malignant breast tumours

13 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Prostaglandins and cancer: A review of tumor initiation through tumor metastasis

13 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

Breast cancer, prostaglandins and patient survival

13 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0952-3278(92)90090-6

13 October 2022

Identifiers

1 reference

27 September 2017

1 reference